Global Molecular Diagnostics Cancer Market Size, Status and Forecast 2020-2026

Global Molecular Diagnostics Cancer Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pharmacogenomic Diagnosis
1.4.3 Liquid Biopsy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Molecular Diagnostics Cancer Market Share by Application: 2020 VS 2026
1.5.2 Respiratory Cancer
1.5.3 Cancer of Digestive System
1.5.4 Cancer of Urinary System
1.5.5 Cancer of Circulatory System
1.5.6 Motor System Cancer
1.5.7 Reproductive System Cancer
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Molecular Diagnostics Cancer Market Perspective (2015-2026)
2.2 Molecular Diagnostics Cancer Growth Trends by Regions
2.2.1 Molecular Diagnostics Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Molecular Diagnostics Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Molecular Diagnostics Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Molecular Diagnostics Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Cancer Players by Market Size
3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2015-2020)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Molecular Diagnostics Cancer Market Concentration Ratio
3.2.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2019
3.3 Molecular Diagnostics Cancer Key Players Head office and Area Served
3.4 Key Players Molecular Diagnostics Cancer Product Solution and Service
3.5 Date of Enter into Molecular Diagnostics Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2021-2026)
5 Molecular Diagnostics Cancer Breakdown Data by Application (2015-2026)
5.1 Global Molecular Diagnostics Cancer Market Size by Application (2015-2020)
5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Molecular Diagnostics Cancer Market Size (2015-2020)
6.2 Molecular Diagnostics Cancer Key Players in North America (2019-2020)
6.3 North America Molecular Diagnostics Cancer Market Size by Type (2015-2020)
6.4 North America Molecular Diagnostics Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Molecular Diagnostics Cancer Market Size (2015-2020)
7.2 Molecular Diagnostics Cancer Key Players in Europe (2019-2020)
7.3 Europe Molecular Diagnostics Cancer Market Size by Type (2015-2020)
7.4 Europe Molecular Diagnostics Cancer Market Size by Application (2015-2020)
8 China
8.1 China Molecular Diagnostics Cancer Market Size (2015-2020)
8.2 Molecular Diagnostics Cancer Key Players in China (2019-2020)
8.3 China Molecular Diagnostics Cancer Market Size by Type (2015-2020)
8.4 China Molecular Diagnostics Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Molecular Diagnostics Cancer Market Size (2015-2020)
9.2 Molecular Diagnostics Cancer Key Players in Japan (2019-2020)
9.3 Japan Molecular Diagnostics Cancer Market Size by Type (2015-2020)
9.4 Japan Molecular Diagnostics Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Molecular Diagnostics Cancer Market Size (2015-2020)
10.2 Molecular Diagnostics Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Molecular Diagnostics Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Molecular Diagnostics Cancer Market Size by Application (2015-2020)
11 India
11.1 India Molecular Diagnostics Cancer Market Size (2015-2020)
11.2 Molecular Diagnostics Cancer Key Players in India (2019-2020)
11.3 India Molecular Diagnostics Cancer Market Size by Type (2015-2020)
11.4 India Molecular Diagnostics Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Molecular Diagnostics Cancer Market Size (2015-2020)
12.2 Molecular Diagnostics Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Molecular Diagnostics Cancer Market Size by Type (2015-2020)
12.4 Central & South America Molecular Diagnostics Cancer Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Molecular Diagnostics Cancer Introduction
13.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Danaher
13.2.1 Danaher Company Details
13.2.2 Danaher Business Overview and Its Total Revenue
13.2.3 Danaher Molecular Diagnostics Cancer Introduction
13.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.2.5 Danaher Recent Development
13.3 Siemens
13.3.1 Siemens Company Details
13.3.2 Siemens Business Overview and Its Total Revenue
13.3.3 Siemens Molecular Diagnostics Cancer Introduction
13.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.3.5 Siemens Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
13.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
13.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 ICON Plc
13.5.1 ICON Plc Company Details
13.5.2 ICON Plc Business Overview and Its Total Revenue
13.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
13.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.5.5 ICON Plc Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview and Its Total Revenue
13.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
13.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.6.5 AstraZeneca Recent Development
13.7 MDxHealth
13.7.1 MDxHealth Company Details
13.7.2 MDxHealth Business Overview and Its Total Revenue
13.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
13.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.7.5 MDxHealth Recent Development
13.8 Invitae
13.8.1 Invitae Company Details
13.8.2 Invitae Business Overview and Its Total Revenue
13.8.3 Invitae Molecular Diagnostics Cancer Introduction
13.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.8.5 Invitae Recent Development
13.9 PlexBio
13.9.1 PlexBio Company Details
13.9.2 PlexBio Business Overview and Its Total Revenue
13.9.3 PlexBio Molecular Diagnostics Cancer Introduction
13.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.9.5 PlexBio Recent Development
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Details
13.10.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
13.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2015-2020)
13.10.5 Thermo Fisher Scientific Recent Development
13.11 Guardant Health
10.11.1 Guardant Health Company Details
10.11.2 Guardant Health Business Overview and Its Total Revenue
10.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
10.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.11.5 Guardant Health Recent Development
13.12 Biocartis
10.12.1 Biocartis Company Details
10.12.2 Biocartis Business Overview and Its Total Revenue
10.12.3 Biocartis Molecular Diagnostics Cancer Introduction
10.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.12.5 Biocartis Recent Development
13.13 Bio-Techne
10.13.1 Bio-Techne Company Details
10.13.2 Bio-Techne Business Overview and Its Total Revenue
10.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
10.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.13.5 Bio-Techne Recent Development
13.14 Merck
10.14.1 Merck Company Details
10.14.2 Merck Business Overview and Its Total Revenue
10.14.3 Merck Molecular Diagnostics Cancer Introduction
10.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.14.5 Merck Recent Development
13.15 Foundation Medicine
10.15.1 Foundation Medicine Company Details
10.15.2 Foundation Medicine Business Overview and Its Total Revenue
10.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
10.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.15.5 Foundation Medicine Recent Development
13.16 10X Genomics
10.16.1 10X Genomics Company Details
10.16.2 10X Genomics Business Overview and Its Total Revenue
10.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
10.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.16.5 10X Genomics Recent Development
13.17 Biodesix
10.17.1 Biodesix Company Details
10.17.2 Biodesix Business Overview and Its Total Revenue
10.17.3 Biodesix Molecular Diagnostics Cancer Introduction
10.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.17.5 Biodesix Recent Development
13.18 CytoTrack
10.18.1 CytoTrack Company Details
10.18.2 CytoTrack Business Overview and Its Total Revenue
10.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
10.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.18.5 CytoTrack Recent Development
13.19 GenomOncology
10.19.1 GenomOncology Company Details
10.19.2 GenomOncology Business Overview and Its Total Revenue
10.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
10.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.19.5 GenomOncology Recent Development
13.20 Luminex
10.20.1 Luminex Company Details
10.20.2 Luminex Business Overview and Its Total Revenue
10.20.3 Luminex Molecular Diagnostics Cancer Introduction
10.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2015-2020)
10.20.5 Luminex Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Molecular Diagnostics Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
Table 3. Ranking of Global Top Molecular Diagnostics Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pharmacogenomic Diagnosis
Table 6. Key Players of Liquid Biopsy
Table 7. Key Players of Other
Table 8. Global Molecular Diagnostics Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Molecular Diagnostics Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Molecular Diagnostics Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Molecular Diagnostics Cancer Market Share by Regions (2015-2020)
Table 12. Global Molecular Diagnostics Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Molecular Diagnostics Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Molecular Diagnostics Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Molecular Diagnostics Cancer Players
Table 19. Global Molecular Diagnostics Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Molecular Diagnostics Cancer Market Share by Players (2015-2020)
Table 21. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2019)
Table 22. Global Molecular Diagnostics Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics Cancer Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Molecular Diagnostics Cancer Market Size Share by Type (2015-2020)
Table 29. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Molecular Diagnostics Cancer Market Size Share by Application (2015-2020)
Table 31. Global Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Molecular Diagnostics Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 35. North America Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 37. North America Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 41. Europe Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 43. Europe Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 47. China Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 49. China Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 53. Japan Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 55. Japan Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 59. Southeast Asia Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 65. India Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 67. India Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Molecular Diagnostics Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Molecular Diagnostics Cancer Market Share (2019-2020)
Table 71. Central & South America Molecular Diagnostics Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Molecular Diagnostics Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Molecular Diagnostics Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Molecular Diagnostics Cancer Market Share by Application (2015-2020)
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Product
Table 78. Roche Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 79. Roche Recent Development
Table 80. Danaher Company Details
Table 81. Danaher Business Overview
Table 82. Danaher Product
Table 83. Danaher Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 84. Danaher Recent Development
Table 85. Siemens Company Details
Table 86. Siemens Business Overview
Table 87. Siemens Product
Table 88. Siemens Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 89. Siemens Recent Development
Table 90. Abbott Laboratories Company Details
Table 91. Abbott Laboratories Business Overview
Table 92. Abbott Laboratories Product
Table 93. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 94. Abbott Laboratories Recent Development
Table 95. ICON Plc Company Details
Table 96. ICON Plc Business Overview
Table 97. ICON Plc Product
Table 98. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 99. ICON Plc Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Product
Table 103. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 104. AstraZeneca Recent Development
Table 105. MDxHealth Company Details
Table 106. MDxHealth Business Overview
Table 107. MDxHealth Product
Table 108. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 109. MDxHealth Recent Development
Table 110. Invitae Business Overview
Table 111. Invitae Product
Table 112. Invitae Company Details
Table 113. Invitae Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 114. Invitae Recent Development
Table 115. PlexBio Company Details
Table 116. PlexBio Business Overview
Table 117. PlexBio Product
Table 118. PlexBio Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 119. PlexBio Recent Development
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Product
Table 123. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 124. Thermo Fisher Scientific Recent Development
Table 125. Guardant Health Company Details
Table 126. Guardant Health Business Overview
Table 127. Guardant Health Product
Table 128. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 129. Guardant Health Recent Development
Table 130. Biocartis Company Details
Table 131. Biocartis Business Overview
Table 132. Biocartis Product
Table 133. Biocartis Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 134. Biocartis Recent Development
Table 135. Bio-Techne Company Details
Table 136. Bio-Techne Business Overview
Table 137. Bio-Techne Product
Table 138. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 139. Bio-Techne Recent Development
Table 140. Merck Company Details
Table 141. Merck Business Overview
Table 142. Merck Product
Table 143. Merck Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 144. Merck Recent Development
Table 145. Foundation Medicine Company Details
Table 146. Foundation Medicine Business Overview
Table 147. Foundation Medicine Product
Table 148. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 149. Foundation Medicine Recent Development
Table 150. 10X Genomics Company Details
Table 151. 10X Genomics Business Overview
Table 152. 10X Genomics Product
Table 153. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 154. 10X Genomics Recent Development
Table 155. Biodesix Company Details
Table 156. Biodesix Business Overview
Table 157. Biodesix Product
Table 158. Biodesix Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 159. Biodesix Recent Development
Table 160. CytoTrack Company Details
Table 161. CytoTrack Business Overview
Table 162. CytoTrack Product
Table 163. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 164. CytoTrack Recent Development
Table 165. GenomOncology Company Details
Table 166. GenomOncology Business Overview
Table 167. GenomOncology Product
Table 168. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 169. GenomOncology Recent Development
Table 170. Luminex Company Details
Table 171. Luminex Business Overview
Table 172. Luminex Product
Table 173. Luminex Revenue in Molecular Diagnostics Cancer Business (2015-2020) (Million US$)
Table 174. Luminex Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2020 VS 2026
Figure 2. Pharmacogenomic Diagnosis Features
Figure 3. Liquid Biopsy Features
Figure 4. Other Features
Figure 5. Global Molecular Diagnostics Cancer Market Share by Application: 2020 VS 2026
Figure 6. Respiratory Cancer Case Studies
Figure 7. Cancer of Digestive System Case Studies
Figure 8. Cancer of Urinary System Case Studies
Figure 9. Cancer of Circulatory System Case Studies
Figure 10. Motor System Cancer Case Studies
Figure 11. Reproductive System Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Molecular Diagnostics Cancer Report Years Considered
Figure 14. Global Molecular Diagnostics Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Molecular Diagnostics Cancer Market Share by Regions: 2020 VS 2026
Figure 16. Global Molecular Diagnostics Cancer Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Molecular Diagnostics Cancer Market Share by Players in 2019
Figure 19. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2019
Figure 21. North America Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Molecular Diagnostics Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 30. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 32. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 34. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 36. ICON Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 38. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 40. MDxHealth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 42. Invitae Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 44. PlexBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 46. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 48. Guardant Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 50. Biocartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 52. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 54. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 56. Foundation Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 58. 10X Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 60. Biodesix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 62. CytoTrack Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 64. GenomOncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 66. Luminex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2015-2020)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs